Drugs for the Treatment of Chronic Hand Eczema: Successes and Key Challenges [Corrigendum]
Dubin C, Del Duca E, Guttman-Yassky E. Ther Clin Risk Manag. 2020;16:1319– 1332. The authors have advised the drug, ARQ-252, was misnamed in the paper as roflumilast (which is called ARQ-151 and ARQ-154 by the manufacturer). The drug named ARQ-252 by the manufact...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/e29c8d896dc34349a1aa8ece5789d99b |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|